Bibliografia
Pivonello R, De Leo M, Cozzolino A, Colao A (2015) The treatment of Cushing’s disease. Endocr Rev 36(4):385–486
Dallapiazza RF, Oldfield EH, Jane JA Jr (2015) Surgical management of Cushing’s disease. Pituitary 18(2):211–216
Biller BM, Grossman AB, Stewart PM et al. (2008) Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 93(7):2454–2462
Lonser RR, Nieman L, Oldfield EH (2017) Cushing’s disease: pathobiology, diagnosis, and management. J Neurosurg 126(2):404–417
Shin SS, Gardner PA, Ng J et al. (2017) Endoscopic endonasal approach for adrenocorticotropic hormone-secreting pituitary adenomas: outcomes and analysis of remission rates and tumor biochemical activity with respect to tumor invasiveness. World Neurosurg 102:651–658
Bochicchio D, Losa M, Buchfelder M (1995) Factors influencing the immediate and late outcome of Cushing’s disease treated by transsphenoidal surgery: a retrospective study by the European Cushing’s Disease Survey Group. J Clin Endocrinol Metab 80(11):3114–3120
Sughrue ME, Shah JK, Devin JK et al. (2010) Utility of the immediate postoperative cortisol concentrations in patients with Cushing’s disease. Neurosurgery 67(3):688–695
Ioachimescu AG (2018) Prognostic factors of long-term remission after surgical treatment of Cushing’s disease. Endocrinol Metab Clin N Am 47(2):335–347
Pendharkar AV, Sussman ES, Ho AL et al. (2015) Cushing’s disease: predicting long-term remission after surgical treatment. Neurosurg Focus 38(2):E13
Carrasco CA, Coste J, Guignat L et al. (2008) Midnight salivary cortisol determination for predicting recurrence in Cushing’s disease assessing the outcome of transsphenoidal surgery in Cushing’s disease. J Clin Endocrinol Metab 93:4728–4734
Raff H (2009) Utility of salivary cortisol measurements in Cushing’s syndrome and adrenal insufficiency. J Clin Endocrinol Metab 94:3647–3655
Amlashi FG, Swearingen B, Faje AT et al. (2015) Accuracy of late-night salivary cortisol in evaluating postoperative remission and recurrence in Cushing’s disease. J Clin Endocrinol Metab 100:3770–3777
Vassiliadi DA, Tsagarakis S (2018) Diagnosis of endocrine disease: the role of the desmopressin test in the diagnosis and follow-up of Cushing’s syndrome. Eur J Endocrinol 178(5):R201–R214
Barbetta L, Dall’Asta C, Tomei G et al. (2001) Assessment of cure and recurrence after pituitary surgery for Cushing’s disease. Acta Neorochir (Wien) 143:477–481
Vassiliadi DA, Balomenaki M, Asimakopoulou A et al. (2016) The desmopressin test predicts better than basal cortisol the long-term surgical outcome of Cushing’s disease. J Clin Endocrinol Metab 101:4878–4885
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflitto di interesse
L’autore Andrea Lania dichiara di non avere conflitti di interesse.
Rights and permissions
About this article
Cite this article
Lania, A. La cortisolemia al mattino rappresenta il miglior predittore disponibile dell’avvenuta guarigione da malattia di Cushing dopo intervento neurochirurgico. L'Endocrinologo 20, 294–295 (2019). https://doi.org/10.1007/s40619-019-00621-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40619-019-00621-1